Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients

被引:2106
作者
Pirmohamed, M [1 ]
James, S
Meakin, S
Green, C
Scott, AK
Walley, TJ
Farrar, K
Park, BK
Breckenridge, AM
机构
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England
[2] Royal Liverpool Univ Hosp, Liverpool L7 8XP, Merseyside, England
[3] Wirral Hosp NHS Trust, Wirral CH49 5PE, Merseyside, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7456期
关键词
D O I
10.1136/bmj.329.7456.15
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To ascertain the current burden of adverse drug reactions (ADRs) through a prospective analysis of all admissions to hospital. Design Prospective observational study. Setting Two large general hospitals in Merseyside, England. Participants 18 820 patients aged > 16 years admitted over six months and assessed for cause of admission. Main outcome measures Prevalence of admissions due to an ADR, length of stay, avoidability, and outcome. Results There were 1225. admissions related to an ADR, giving a prevalence of 6.5%, with the ADR directly leading to the admission in 80% of cases. The median bed stay was eight days, accounting for 4% of the hospital bed capacity. The projected annual cost of such admissions to the NHS is pound466m ((sic)706m, $847m). The overall fatality was 0.15%. Most reactions were either definitely or possibly avoidable. Drugs most commonly implicated in causing these admissions included low dose aspirin, diuretics, warfarin, and non-steroidal anti-inflammatory drugs other than aspirin, the most common reaction being gastrointestinal bleeding. Conclusion The burden of ADRs on the NHS is high accounting for considerable morbidity, mortality, and extra costs. Although many of the implicated drugs have proved benefit, measures need to be put into place to reduce the burden of ADRs and thereby further improve the benefit:harm ratio of the drugs.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 33 条
  • [1] The costs of adverse drug events in hospitalized patients
    Bates, DW
    Spell, N
    Cullen, DJ
    Burdick, E
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Leape, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04): : 307 - 311
  • [2] Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies
    Beijer, HJM
    de Blaey, CJ
    [J]. PHARMACY WORLD & SCIENCE, 2002, 24 (02): : 46 - 54
  • [3] BHALLA N, 2003, PHARM J, V270, P583
  • [4] *BRIT MED ASS ROYA, 2002, BRIT NAT FORM
  • [5] *CIPFA, 2002, HLTH SERV FIN DAT CO
  • [6] Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality
    Classen, DC
    Pestotnik, SL
    Evans, RS
    Lloyd, JF
    Burke, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04): : 301 - 306
  • [7] *DEP HLTH, 2001, HOSP EP STAT
  • [8] Department of Health, 2001, MED OLD PEOPL IMPL M
  • [9] Adverse drug reactions: definitions, diagnosis, and management
    Edwards, IR
    Aronson, JK
    [J]. LANCET, 2000, 356 (9237) : 1255 - 1259
  • [10] DRUG-RELATED HOSPITAL ADMISSIONS
    EINARSON, TR
    [J]. ANNALS OF PHARMACOTHERAPY, 1993, 27 (7-8) : 832 - 840